autism

SNAP Contact Form

The UCSF Pediatric Brain Center’s Sensory Neurodevelopment and Autism Program is committed to conducting new and relevant research. We frequently begin new studies that you or your child might be eligible for. This SNAP Contact Form allows us to keep you informed of new studies through email, phone and periodic newsletters.

The UCSF Pediatric Brain Center’s Sensory Neurodevelopment and Autism Program is committed to conducting new and relevant research. We frequently begin new studies that you or your child might be eligible for. This SNAP Contact Form allows us to keep you informed of new studies through email, phone and periodic newsletters. You may also contact Annie Brandes-Aitken at Anne.Brandes-Aitken@ucsf.edu for more information.

Autism Trial with Vitamin D

The study is a 12-week, open-label trial examining the tolerability of Vitamin D replacement in children with autism spectrum disorders. The study will evaluate whether Vitamin D replacement at high doses will show improvement in the core symptoms of autism, including sociability, eye contact, anger outbursts, stimming behavior, and sleep.

Summary

  • Study director: Robert Hendren, DO
  • Sponsor: Ddrops
  • Recruiting?: No
  • Official study title: Open Label Clinical trial of Vitamin D3 Dosage Tolerability and Effect on Behavioral Measures in Children with Autism
  • ClinicalTrials.gov identifier: Pending
  • Conditions studied: Autistic disorder
  • Intervention: Vitamin D3 (cholecalciferol)
  • Phase: Phase II

Adult Outcomes in Autism

In the past 15 years, estimates of autism prevalence have increased from 1:800 (DSM-IV, APA, 1994) to as high as 1:110 presently (2008, CDC). If as data suggest, most adults have limited prognoses, studying predictors of outcomes among those currently just reaching adulthood can provide an understanding of how to provide positive and cost-effective treatment.

Summary

  • Study director: Bryna Siegel, PhD
  • Sponsor: UCSF
  • Recruiting?: Yes
  • Official study title: Early Childhood Predictors of Adult Outcomes in Autism
  • Conditions studied: Adults who were diagnosed with an autism spectrum disorder before the age of 4 at the UCSF Autism Clinic

JumpStart Learning to Learn

The purpose of the study is to evaluate child and parent outcomes after participation in the treatment program JumpStart Learning-to-Learn (JSLTL). JSLTL is a new approach to early intervention for autism, best characterized as a "first intervention" consisting of an intensive, full-time week of parent and child trainings.

Summary

  • Study director: Bryna Siegel, PhD
  • Sponsor: Flora Foundation
  • Recruiting?: Yes
  • Official study title: Outcomes of JumpStart Learning to Learn
  • Conditions studied: Families with children recently diagnosed with autism who have participated in an intensive early intervention parent training program (JumpStart Learning to Learn)
  • Intervention: JumpStart Learning-to-Learn (JSLTL)

Brain Development Research Program Study

We are studying the clinical, genetic, and radiographic features of brain malformation disorders to better understand the problems that individuals affected by these disorders are likely to face. The goal of our research is to develop a better understanding of the underlying genetic causes as a foundation for devising better treatments for these groups of patients.

Summary

  • Study director: Elliott Sherr, MD PhD
  • Sponsor: NIH and private foundations and grants
  • Recruiting?: Yes
  • Official study title: Brain Development Research Program
  • Conditions studied: Disorders of brain development that are visible on an MRI (or other imaging study) and/or disorders of brain development that have been clinically diagnosed, such as autism, epilepsy or cerebral palsy.

Simons Variation in Individuals Project

The purpose of this project is to characterize the clinical and behavior features associated with specific genetic mutations likely to be involved in ASD or other neurodevelopmental disorders. Currently Simons VIP is focused on 16p11.2 deletions and duplications, the most common genetic disorder associated with ASD. The end goal of our project is to develop science-based solutions and targeted treatments to improve the lives of individuals with genetic and developmental differences.

Summary

  • Study director: Elliott Sherr, MD PhD
  • Sponsor: The Simons Foundation
  • Recruiting?: Yes
  • Official study title: Simons Variations in Individuals Project
  • Conditions studied: Genetic mutations likely to be involved in ASD and other neurodevelopmental disorders. Currently we are investigating only copy number variations of 16p11.2.

Genetic Expression Mapping to Identify Networks of Functionally Related Autism Risk Genes

In this project, we use an approach to “pathway” definition using gene expression data that can unite a number of autism-implicated common polymorphisms and rare variants into a network with functional implications.

Summary

  • Study director: Lauren Weiss, PhD
  • Sponsor: Brain and Behavior Research Foundation
  • Official study title: Genetic expression mapping of functionally related autism risk genes

Identification of Maternal Genetic Risk Factors and Gene X Environment Interactions in Autism

This study will investigate maternal genetic factors for the Early Markers for Autism study, an ongoing epidemiologic investigation of immunologic and environmental markers for ASDs in maternal prenatal and newborn blood samples.

Summary

  • Study director: Lauren Weiss, PhD
  • Sponsor: NIH
  • Official study title: Early Markers for Autism study

Neurodevelopmental Pediatrics for ADHD and Autism at the Osher Integrative Medicine Center

The Neurodevelopmental Clinic at the Osher Center for Integrative Medicine is headed by Sanford C. Newmark, MD. Dr. Newmark specializes in the integrative and holistic treatment of children with autism and ADHD. He combines conventional medicine with nutrition, behavior management and various complementary modalities. Working with Dr. Newmark in this clinic are Dionne Detraz, integrative nutritionist, and Kimberly Tompkins, child psychologist. We strive to work seamlessly with the ANP clinics to provide comprehensive evaluation and care.

The Neurodevelopmental Clinic at the Osher Center for Integrative Medicine is headed by Sanford C. Newmark, MD. Dr. Newmark specializes in the integrative and holistic treatment of children with Autism and ADHD. He combines conventional medicine with nutrition, behavior management and various complementary modalities. Working with Dr. Newmark in this clinic are Dionne Detraz, integrative nutritionist, and Kimberly Tompkins, child psychologist. We strive to work seamlessly with the ANP clinics to provide comprehensive evaluation and care.

Location

Phone numbers:

Syndicate content